James Noble

Insider Reports History

Location
Abingdon, Oxfordshire
Signature
/s/ Amy Garabedian, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Noble:

Company Role Class Num Shares Value Price $ Report Date Ownership
Adaptimmune Therapeutics PLC Director Option to purchase Ordinary Shares 710,711 01 Jul 2022 Direct
LAVA Therapeutics NV Director Common Shares (Right to Buy) 33,390 13 Feb 2025 Direct
GW PHARMACEUTICALS PLC Director Ordinary Shares 0 05 May 2021 Direct
GW PHARMACEUTICALS PLC Director Share Options 0 05 May 2021 Direct
LAVA Therapeutics NV Director Share Options (Right to Buy) 0 13 Nov 2025 Direct

Insider Reports Filed by James Noble

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LVTX LAVA Therapeutics NV 13 Nov 2025 1 $0 4 Director 17 Nov 2025, 16:30
LVTX LAVA Therapeutics NV 13 Feb 2025 1 $0 4 Director 18 Feb 2025, 20:15
LVTX LAVA Therapeutics NV 01 Jan 2025 0 $0 3 Director 02 Jan 2025, 09:31
ADAP Adaptimmune Therapeutics PLC 01 Jul 2022 1 $0 4 Director 01 Jul 2022, 17:02
ADAP Adaptimmune Therapeutics PLC 01 Jul 2021 1 $0 4 Director 02 Jul 2021, 17:02
/report/000089924321018665-noble-james-2021-05-05 GW PHARMACEUTICALS PLC 05 May 2021 9 $0 4 Director 07 May 2021, 16:15